- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04006509
Prenatal Breast Pump Education of Mothers and Their Support Person
May 15, 2024 updated by: University of Florida
Prenatal Breast Pumping Education of Mothers and Their Support Person
The study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test whether antenatal education of the support person of mothers may decrease time to initiation of breast pumping, decrease time to lactogenesis stage II and increase breast milk production.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Compelling evidence exists that breast milk helps protect premature infants from prematurity-specific morbidities, including feeding intolerance, late onset sepsis, and necrotizing enterocolitis.
Unfortunately, mothers of VLBW infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and inadequate breast milk production.
Earlier initiation of breast milk expression following delivery is associated with increased lactation success.
However, lack of nursing time and lack of hospital personal are significant barriers to the early initiation of milk expression in this population.
The proposed study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test 1 primary aim and 1 secondary aim.
Aim 1: will evaluate the feasibility of antenatal BM pumping education for SPs of mothers of preterm infants.
Issues related to recruitment, randomization acceptance of the intervention, and refinement of the education materials and process will be scrutinized.
Aim 2 will estimate variability of outcome measurements and effect sizes needed to calculate the sample size for a subsequent larger, adequately powered, randomized clinical trial.
Eligible women and their SP will be randomly assigned to one of two groups.
Group 1 will receive a prenatally delivered lactation educational program including video recordings, a demonstration of how the pump works and will have a breast pump available in their room.
The volume of breast milk produced, timing of lactation stage II, duration of lactation and stress during initial expression will be measured.
In addition, breast milk sodium levels will be analyzed on Day 1-7, Day 14 and 21.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health at the University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- English speaking
- stated intent to breastfeed
- anticipating the birth of a premature infant < 35 weeks gestation.
Exclusion Criteria:
- known illicit maternal drug use
- history of breast reduction or augmentation
- positive HIV status
- infant not expected to live over 2 weeks following delivery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Antenatal Education Group
Patients will receive a prenatally delivered lactation educational program.
|
The support person (SP) of mothers at risk for preterm birth will be educated on how to use a breast pump and instructions regarding breast milk expression and have a pump in their hospital room
Other Names:
|
|
No Intervention: Standard of Care Group
Patients will receive standard of care and not a prenatally delivered lactation educational program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Onset of Lactogenesis Stage II Through Volume Attainment
Time Frame: Up to 96 Hours
|
Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions
|
Up to 96 Hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breast Milk Production on Day 1
Time Frame: 0-24 hours postpartum
|
Volume of breast milk produced from 0-24 hours postpartum
|
0-24 hours postpartum
|
|
Time to Breast Pumping Initiation
Time Frame: first 24 hours after delivery
|
Time to mothers beginning to pump breasts after delivery
|
first 24 hours after delivery
|
|
Breast Milk Production Day 2
Time Frame: Day 2 postpartum
|
Volume of breast milk produced on day 2 postpartum
|
Day 2 postpartum
|
|
Milk Production Day 3
Time Frame: 3 days postpartum
|
Volume of milk produced on Day 3 postpartum
|
3 days postpartum
|
|
Breast Milk Production Day 4
Time Frame: Day 4 postpartum
|
Volume of breast milk produced on Day 4 postpartum
|
Day 4 postpartum
|
|
Breast Milk Production on Day 5
Time Frame: Day 5 postpartum
|
Volume of breast milk produced on Day 5 postpartum
|
Day 5 postpartum
|
|
Breast Milk Production Day 6
Time Frame: Day 6 postpartum
|
Volume of breast milk produced on Day 6 postpartum
|
Day 6 postpartum
|
|
Breast Milk Production Day 7
Time Frame: Day 7 postpartum
|
Volume of milk produced on Day 7 postpartum
|
Day 7 postpartum
|
|
Breast Milk Production Day 14
Time Frame: Day 14 postpartum
|
Volume of breast milk produced on Day 14 postpartum
|
Day 14 postpartum
|
|
Breast Milk Production Day 21
Time Frame: 21 days postpartum
|
Volume of breast milk produced on Day 21 postpartum
|
21 days postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Leslie A Parker, University of Florida
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 6, 2018
Primary Completion (Actual)
May 4, 2022
Study Completion (Actual)
May 4, 2022
Study Registration Dates
First Submitted
July 1, 2019
First Submitted That Met QC Criteria
July 1, 2019
First Posted (Actual)
July 5, 2019
Study Record Updates
Last Update Posted (Actual)
May 21, 2024
Last Update Submitted That Met QC Criteria
May 15, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P0081761
- IRB201400318 (Other Identifier: University of Florida)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
University of WashingtonRecruitingVery Preterm and Extremely Preterm BirthUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Thomas Jefferson UniversityCompleted
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on Prenatally Delivered Lactation Educational Program
-
National University Hospital, SingaporeCompleted
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)Recruiting
-
University of Wisconsin, MadisonColumbia University; University of Illinois at Chicago; Washington State University and other collaboratorsRecruiting
-
Norwegian University of Science and TechnologyCompletedFecal Incontinence | Staffs' AttitudesNorway
-
Chinese University of Hong KongCompletedPsychological Distress | OncologyHong Kong
-
University of British ColumbiaMood Disorders Association of OntarioNot yet recruitingBipolar Disorder (BD) | Quality of Life (QOL)Canada
-
University of BarcelonaFundació La Marató de TV3; SHE Foundation; Centro Nacional de Investigaciones... and other collaboratorsActive, not recruitingObesity | Diabetes Mellitus | Cardiovascular HealthSpain
-
Universidade Nova de LisboaCompletedAnxiety | Prescription Drug Abuse and DependencyPortugal
-
Medical University of GrazCompleted
-
Oral Health Centre of Expertise in Western NorwayEducational storytelling forlag og filmCompletedChild Abuse | Oral Health | Child Neglect | Child Maltreatment | Child Sexual Abuse | Dental NeglectNorway